Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation

References

• MeshnickSRDobsonMJThe history of antimalarial drugsRosenthalPJAntimalarial ChemotherapySpringer20011525
   Google Scholar
• BhattSWeissDCameronEThe effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015Nature2015526757220721126375008
   PubMed Web of Science ®Google Scholar
• SnounouGViriyakosolSJarraWThaithongSBrownKNIdentification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infectionsMol Biochem Parasitol19935822832928479452
   PubMed Web of Science ®Google Scholar
• WiesnerJOrtmannRMitschAInhibitors of farnesyltransferase: 5-arylacryloyl-aminobenzophenones show antimalarial activityInt J Pharm Sci2003584289290
   Google Scholar
• WiesnerJKettlerKSakowskiJFarnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivoAngew Chem Int Ed2004432251254
   PubMed Web of Science ®Google Scholar
• WiesnerJOrtmannRJomaaHSchlitzerMDouble ester prodrugs of FR900098 display enhanced in-vitro antimalarial activityArch Pharm (Weinheim)20073401266766917994601
   PubMed Web of Science ®Google Scholar
• KhatoonLBaliraineFNBonizzoniMMalikSAYanGGenetic structure of Plasmodium vivax and Plasmodium falciparum in the Bannu district of PakistanMalar J20109111220416089
   PubMedGoogle Scholar
• WHOWorld Malaria Report 2011GenevaWorld Health Organization2011
   Google Scholar
• BasseriHRaeisiAHolakouieKShanadehKMalaria prevention among afghan refugees in a malarious area, southeastern IranBull Soc Pathol Exot2010103534034520526828
   PubMedGoogle Scholar
• PaniskoDMKeystoneJSTreatment of malaria – 1990Drugs19903921601892183998
   PubMed Web of Science ®Google Scholar
• OkiroEAAleganaVANoorAMSnowRWChanging malaria intervention coverage, transmission and hospitalization in KenyaMalar J20109285
   Google Scholar
• NayyarGMBremanJGNewtonPNHerringtonJPoor-quality antimalarial drugs in southeast Asia and sub-Saharan AfricaLancet Infect Dis201212648849622632187
   PubMed Web of Science ®Google Scholar
• FaladeCMakangaMPremjiZOrtmannC-EStockmeyerMde PalaciosPIEfficacy and safety of artemether–lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malariaTrans R Soc Trop Med Hyg200599645946715837358
   PubMedGoogle Scholar
• RidleyRGMedical need, scientific opportunity and the drive for antimalarial drugsNature2002415687268669311832957
   PubMed Web of Science ®Google Scholar
• BunnagDViravanCLooareesuwanSKarbwangJHarinasutaTClinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary reportSoutheast Asian J Trop Med Public Health19912233803851818389
   PubMedGoogle Scholar
• El-DakdokyMEvaluation of the developmental toxicity of artemether during different phases of rat pregnancyFood Chem Toxicol20094771437144119332101
   PubMed Web of Science ®Google Scholar
• KlaymanDLQinghaosu (artemisinin): an antimalarial drug from ChinaScience19852284703104910553887571
   PubMed Web of Science ®Google Scholar
• FuleRAMeerTSSavARAminPDArtemether-soluplus hot-melt extrudate solid dispersion systems for solubility and dissolution rate enhancement with amorphous state characteristicsJ Pharm (Cairo)2013201315143226555968
   PubMedGoogle Scholar
• SinhaSMedhiBSehgalRChallenges of drug-resistant malariaParasite2014216125402734
   PubMed Web of Science ®Google Scholar
• TayadeNNagarsenkerMSDevelopment and evaluation of artemether parenteral microemulsionIndian J Pharm Sci201072563721694999
   PubMed Web of Science ®Google Scholar
• UmapathiPAyyappanJQuineSDDevelopment and validation of a dissolution test method for artemether and lumefantrine in tabletsTrop J Pharm Res2011105643653
   Web of Science ®Google Scholar
• MandawgadeSDSharmaSPathakSPatravaleVBDevelopment of SMEDDS using natural lipophile: application to β-artemether deliveryInt J Pharm2008362117918318652886
   PubMedGoogle Scholar
• SerajuddinASolid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughsJ Pharm Sci199988101058106610514356
   PubMed Web of Science ®Google Scholar
• AungstBJNovel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolismJ Pharm Sci199382109799878254497
   PubMed Web of Science ®Google Scholar
• JangD-JJeongEJLeeH-MKimB-CLimS-JKimC-KImprovement of bioavailability and photostability of amlodipine using redispersible dry emulsionEur J Pharm Sci200628540541116777390
   PubMed Web of Science ®Google Scholar
• LawrenceMJReesGDMicroemulsion-based media as novel drug delivery systemsAdv Drug Deliv Rev20004518912111104900
   PubMed Web of Science ®Google Scholar
• SahuGSharmaHGuptaAKaurCAdvancements in microemulsion based drug delivery systems for better therapeutic effectsInt J Pharm Sci Dev Res201511008015
   Google Scholar
• CharoenchaitrakoolMDehghaniFFosterNChanHMicronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticalsInd Eng Chem Res2000391247944802
   Web of Science ®Google Scholar
• VoCL-NParkCLeeB-JCurrent trends and future perspectives of solid dispersions containing poorly water-soluble drugsEur J Pharm Biopharm201385379981324056053
   PubMed Web of Science ®Google Scholar
• SchwarzCMehnertWLucksJMüllerRSolid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilizationJ Control Release19943018396
   Web of Science ®Google Scholar
• PattniBSChupinVVTorchilinVPNew developments in liposomal drug deliveryChem Rev201511519109381096626010257
   PubMed Web of Science ®Google Scholar
• LoftssonTBrewsterMEPharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilizationJ Pharm Sci19968510101710258897265
   PubMed Web of Science ®Google Scholar
• JonesM-CLerouxJ-CPolymeric micelles – a new generation of colloidal drug carriersEur J Pharm Biopharm199948210111110469928
   PubMed Web of Science ®Google Scholar
• HuangYDaiW-GFundamental aspects of solid dispersion technology for poorly soluble drugsActa Pharm Sin B201441182526579360
   PubMed Web of Science ®Google Scholar
• NarangASDelmarreDGaoDStable drug encapsulation in micelles and microemulsionsInt J Pharm2007345192517945446
   PubMedGoogle Scholar
• Merisko-LiversidgeELiversidgeGGCooperERNanosizing: a formulation approach for poorly water-soluble compoundsEur J Pharm Sci200318211312012594003
   PubMed Web of Science ®Google Scholar
• KhadkaPRoJKimHPharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailabilityAsian J Pharm Sci201496304316
   Google Scholar
• O’MahonyMLeungAKFergusonSTroutBLMyersonASA process for the formation of nanocrystals of active pharmaceutical ingredients with poor aqueous solubility in a nanoporous substrateOrg Process Res Dev201519911091118
   Web of Science ®Google Scholar
• KhanSMatasMDZhangJAnwarJNanocrystal preparation: low-energy precipitation method revisitedCryst Growth Des201313727662777
   Web of Science ®Google Scholar
• LiMAzadMDavéRBilgiliENanomilling of drugs for bioavailability enhancement: a holistic formulation-process perspectivePharmaceutics20168217
   PubMed Web of Science ®Google Scholar
• SchadeHKolloidchemie und BalneologieColloid Polym Sci19095128
   Google Scholar
• FreundlichHNeuere Fortschritte der Kolloidchemie und ihre biologische BedeutungProtoplasma192721278299
   Google Scholar
• WuWNancollasGHA new understanding of the relationship between solubility and particle sizeJ Solution Chem1998276521531
   Web of Science ®Google Scholar
• MüllerRJacobsCKayserONanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the futureAdv Drug Deliv Rev200147131911251242
   PubMed Web of Science ®Google Scholar
• PlakkotSDe MatasMYorkPSaundersMSulaimanBComminution of ibuprofen to produce nano-particles for rapid dissolutionInt J Pharm20114151–230731421683776
   PubMedGoogle Scholar
• SulaimanBInventorThe Milling SystemPatentWO/2007/02040720072007
   Google Scholar
• Van EerdenbrughBVermantJMartensJASolubility increases associated with crystalline drug nanoparticles: methodologies and significanceMol Pharm2010751858187020822111
   PubMedGoogle Scholar
• GaoLZhangDChenMDrug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery systemJ Nanopart Res2008105845862
   Web of Science ®Google Scholar
• ThakkarHNangeshJParmarMPatelDFormulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery systemJ Pharm Bioallied Sci20113344221966167
   PubMedGoogle Scholar
• PawarJNSheteRTGangurdeABDevelopment of amorphous dispersions of artemether with hydrophilic polymers via spray drying: physicochemical and in silico studiesAsian J Pharm Sci2016113385395
   Web of Science ®Google Scholar
• ShekunovBYChattopadhyayPSeitzingerJHuffRNanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsionsPharm Res200623119620416307386
   PubMed Web of Science ®Google Scholar
• TragerWJensenJBHuman malaria parasites in continuous cultureScience19761934254673675781840
   PubMed Web of Science ®Google Scholar
• FidockDARosenthalPJCroftSLBrunRNwakaSAntimalarial drug discovery: efficacy models for compound screeningNat Rev Drug Discov20043650952015173840
   PubMed Web of Science ®Google Scholar
• PetersWThe chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activityAnn Trop Med Parasitol19756921551711098584
   PubMed Web of Science ®Google Scholar
• OECDAcute Inhalation Toxicity – Fixed Concentration Procedure Available from: http://www.oecd.org/dataoecd/63/7/32035886.pdfAccessed February 2, 2008
   Google Scholar
• StengerFPeukertWThe role of particle interactions on suspension rheology–application to submicron grinding in stirred ball millsChem Eng Tech2003262177183
   Web of Science ®Google Scholar
• YangJZYoungALChiangPCThurstonAPretzerDKFluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studiesJ Pharm Sci200897114869487818351635
   PubMed Web of Science ®Google Scholar
• JacobsCMüllerRHProduction and characterization of a budesonide nanosuspension for pulmonary administrationPharm Res200219218919411883646
   PubMed Web of Science ®Google Scholar
• AliHSYorkPBlagdenNPreparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactorsInt J Pharm2009375110711319481696
   PubMedGoogle Scholar
• PlakkotSde MatasMYorkPSaundersMSulaimanBComminution of ibuprofen to produce nanoparticles for rapid dissolutionInt J Pharm20114151–230731421683776
   PubMed Web of Science ®Google Scholar
• DengJHuangLLiuFUnderstanding the structure and stability of paclitaxel nanocrystalsInt J Pharm2010390224224920167270
   PubMed Web of Science ®Google Scholar
• WuLZhangJWatanabeWPhysical and chemical stability of drug nanoparticlesAdv Drug Deliv Rev201163645646921315781
   PubMed Web of Science ®Google Scholar
• FreitasCMüllerRHEffect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersionsInt J Pharm19981682221229
   Web of Science ®Google Scholar
• BunjesHKochMHWestesenKEffect of particle size on colloidal solid triglyceridesLangmuir2000161252345241
   Web of Science ®Google Scholar
• ValleriMMuraPMaestrelliFCirriMBalleriniRDevelopment and evaluation of glyburide fast dissolving tablets using solid dispersion techniqueDrug Dev Ind Pharm200430552553415244088
   PubMed Web of Science ®Google Scholar
• AliHSYorkPAliAMBlagdenNHydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and wet millingJ Control Release2011149217518120946923
   PubMed Web of Science ®Google Scholar
• LeunerCDressmanJImproving drug solubility for oral delivery using solid dispersionsEur J Pharm Biopharm2000501476010840192
   PubMed Web of Science ®Google Scholar
• AzizHATanYTFPehKKSolubility of drugs in aqueous polymeric solution: effect of ovalbumin on microencapsulation processAAPS PharmSciTech2012131354522101965
   PubMed Web of Science ®Google Scholar
• KesisoglouFPanmaiSWuYNanosizing – oral formulation development and biopharmaceutical evaluationAdv Drug Del Rev2007597631644
   PubMed Web of Science ®Google Scholar
• JunghannsJ-UAHMuellerRHNanocrystal technology, drug delivery and clinical applicationsInt J Nanomedicine20083329530918990939
   PubMed Web of Science ®Google Scholar
• KayaertPVan den MooterGIs the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with naproxen and cinnarizineEur J Pharm Biopharm201281365065622579733
   PubMed Web of Science ®Google Scholar
• PatravaleVDateAAKulkarniRNanosuspensions: a promising drug delivery strategyJ Pharm Pharmacol200456782784015233860
   PubMed Web of Science ®Google Scholar
• ZhouYNingDWangSAntimalarial compositionsGoogle Patents1997
   Google Scholar